Morning Overview on MSN
Long COVID brain scans just overturned the leading theory — there’s no widespread brain inflammation, but anxiety and depression light up memory centers instead
For years, the working theory was straightforward: SARS-CoV-2 triggers lasting inflammation throughout the brain, and that ...
A new brain imaging test can detect a key hallmark of Alzheimer's disease before symptoms appear and earlier than the method ...
A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the ...
PET brain scans from the same individual with early signs of Alzheimer’s disease comparing two tau radiotracers: flortaucipir ...
Advanced brain imaging using a next-generation tau tracer revealed more Alzheimer’s-related pathology than current methods, ...
VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce NovaScan ...
A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has identified important differences in how early ...
A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated with repeated head impact. Rather ...
Detailed price information for Grey Matters Health Inc (AGNPF) from The Globe and Mail including charting and trades.
A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results